DBV Technologies | Marketskapitalisme

Market Capitalization Endring Dato
Acadia Pharmaceuticals USD 5.14B 1.73B 2023-12
Alnylam Pharmaceuticals USD 24.02B 1.88B 2023-12
Amarin USD 355M 20M 2023-12
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
BioMarin Pharmaceutical USD 18.16B 1.51B 2023-12
Esperion Therapeutics USD 340M 235M 2023-12
Galectin Therapeutics USD 103M 11M 2023-12
Halozyme Therapeutics USD 4.88B 157M 2023-12
Incyte USD 12.89B 1.18B 2024-03
Insmed USD 3.95B 486M 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
PTC Therapeutics USD 2.22B 145M 2024-03
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03
United Therapeutics USD 11.05B 721M 2024-03



DBV Technologies Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.